文献速递冠心病

光子计数探测器CT在冠心病中的诊断性能与临床影响

Diagnostic Performance and Clinical Impact of Photon-Counting Detector Computed Tomography in Coronary Artery Disease.
PubMed 文献 · J Am Coll Cardiol · 2024-10-28

该单中心回顾性研究纳入2022至2023年7833例接受冠状动脉CT血管造影的患者,比较光子计数探测器CT(PCD-CT)与常规能量积分探测器CT(EID-CT)对阻塞性冠心病的诊断性能及临床影响。以定量冠状动脉造影为参考标准,PCD-CT提高了特异性、阳性预测值和诊断准确率,且PCD-CT组转诊有创冠状动脉造影的比例更低,但转诊者接受血运重建的比例更高。

要点

  • PCD-CT较EID-CT提高了诊断阻塞性冠心病的特异性、阳性预测值和准确率。
  • PCD-CT组转诊有创冠状动脉造影的比例低于EID-CT组(9.9% vs 13.1%)。
  • 转诊有创冠状动脉造影者中,PCD-CT组血运重建比例高于EID-CT组(43.4% vs 35.5%)。

核心结论

  • PCD-CT对阻塞性冠心病表现出优异的诊断性能,与EID-CT相比提高了特异性、阳性预测值和诊断准确率。
  • PCD-CT组转诊有创冠状动脉造影的患者更少,但转诊者接受血运重建的比例更高。

研究设计与样本

  • 单中心回顾性研究,纳入2022至2023年连续7833例临床指征行冠状动脉CT血管造影的患者,PCD-CT组3876例,EID-CT组3957例。
  • 以有创冠状动脉造影定量冠状动脉分析(≥50%直径狭窄)为参考标准,盲法比较两种CT对阻塞性冠心病的诊断性能。

主要发现

  • PCD-CT组转诊有创冠状动脉造影的比例低于EID-CT组(9.9% vs 13.1%;P < 0.001)。
  • 转诊有创冠状动脉造影者中,PCD-CT组血运重建比例高于EID-CT组(43.4% vs 35.5%;P = 0.02)。
  • 血管水平分析(n = 1,686)显示PCD-CT较EID-CT提高了特异性(98.0% vs 93.0%;P < 0.001)、阳性预测值(83.3% vs 63.0%;P = 0.002)和诊断准确率(97.2% vs 92.8%;P < 0.001)。
  • 敏感度(90.9% vs 90.7%;P = 0.95)和阴性预测值(98.9% vs 98.7%;P = 0.83)在两组间相似。

关键数值与推荐

  • 阻塞性冠心病在冠状动脉CT上定义为视觉评估重度狭窄(依据CAD-RADS),在有创冠状动脉造影上定义为定量冠状动脉分析≥50%直径狭窄。
  • PCD-CT组转诊有创冠状动脉造影比例9.9%,EID-CT组13.1%(P < 0.001)。
  • 血管水平分析中PCD-CT与EID-CT的特异性分别为98.0%与93.0%(P < 0.001),阳性预测值分别为83.3%与63.0%(P = 0.002),诊断准确率分别为97.2%与92.8%(P < 0.001)。

临床怎么用

  • PCD-CT可作为评估阻塞性冠心病的高诊断性能无创影像工具,有助于提高阳性发现的特异性与阳性预测值。
  • PCD-CT可能减少不必要的转诊有创冠状动脉造影,同时使转诊者中血运重建比例更高。

局限性

  • 本研究为单中心回顾性研究,结果可能受中心实践模式影响。
  • 仅对转诊有创冠状动脉造影的患者进行了血管水平诊断性能分析,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Photon-counting detector-computed tomography (PCD-CT) has emerged as a promising technology, offering improved spatial resolution. OBJECTIVES: This study aimed to evaluate the clinical impact and diagnostic performance of PCD-CT vs conventional energy-integrating detector computed tomography (EID-CT) for obstructive coronary artery disease (CAD). METHODS: From 2022 to 2023, we retrospectively identified 7,833 consecutive patients who underwent clinically indicated coronary computed tomography angiography (CCTA) at a single center, with either PCD-CT (n = 3,876; NAEOTOM Alpha [Siemens Healthineers]) or EID-CT (n = 3,957; Revolution Apex 256 [GE HealthCare] or Aquilion ONE ViSION 320 [Canon Medical Systems]) scanners. Subsequent invasive coronary angiography (ICA) and percutaneous or surgical revascularization were performed as part of routine clinical care. Among those referred for ICA after coronary CTA, the presence of obstructive CAD in each vessel was determined by coronary CTA (severe stenosis on visual assessment per the Coronary Artery Disease Reporting and Data System) and ICA (≥50% diameter stenosis on quantitative coronary angiography) in a blinded fashion. The diagnostic performance of EID-CT and PCD-CT was compared by using quantitative coronary angiography as the reference standard. RESULTS: Patients who underwent PCD-CT were less frequently referred to subsequent ICA than those undergoing EID-CT (9.9% vs 13.1%; P < 0.001). Among those who underwent ICA, revascularization was more frequently performed in the PCD-CT group than in the EID-CT group (43.4% vs 35.5%; P = 0.02). In the vessel-level analysis (n = 1,686), specificity (98.0% vs 93.0%; P < 0.001), positive predictive value (83.3% vs 63.0%; P = 0.002), and diagnostic accuracy (97.2% vs 92.8%; P < 0.001) were improved by PCD-CT. Sensitivity (90.9% vs 90.7%; P = 0.95) and negative predictive value (98.9% vs 98.7%; P = 0.83) for obstructive CAD were similar between the PCD-CT and EID-CT groups, respectively. CONCLUSIONS: PCD-CT exhibited excellent diagnostic performance for detecting obstructive CAD. Compared with patients undergoing conventional EID-CT, fewer patients were referred to ICA after PCD-CT, but those referred were more likely to undergo revascularization.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Sakai K, Shin D, Singh M, et al. Diagnostic Performance and Clinical Impact of Photon-Counting Detector Computed Tomography in Coronary Artery Disease. J Am Coll Cardiol. 2024. PMID: 39466216. doi:10.1016/j.jacc.2024.10.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。